| Issuing Duplicate Prescriptions |
Sep 2020 |
Community Pharmacy Letter May 2015 |
| Community Pharmacies re Instalment Dispensing |
Dec 2019 |
Letter to Community Pharmacies |
| Comm Proforma For Changes |
Dec 2019 |
|
| Communication Of Instalment Dispensing Medication Changes |
Dec 2019 |
Letter to All GP Practices |
| Cannabis Based Products For Pain |
Mar 2019 |
Letter to GPs, PBPs, CPs and Trust Chief Executives |
| Prescription Ordering Arrangements |
Sep 2018 |
Professional letter to CPs and GPs |
| Serious adverse incident: dispensing Paracetamol without Child Resistant Closure |
Aug 2018 |
Letter to Community Pharmacists, dispensing Doctors and GP practices |
| Risk Of Human Error With Robotic Dispensing Systems In Community Pharmacy |
Apr 2018 |
Learning Letter |
| Learning From Adverse Incidents Configuration Of Drug Interactions |
Mar 2018 |
Letter to clinical governance leads, practice managers, all prescribers |
| Draft Pharmacy (Preparation And Dispensing Errors - Registered Pharmacies) Order 2018 |
Jan 2018 |
Summary Document |
| Fire Risk With Hedrin 4% Cutaneous Solution |
Jan 2018 |
Alert Letter |
| Patient Reminder Note For Special Order Medicines |
Mar 2017 |
Learning letter |
| Learning From Serious Adverse Incidents |
Feb 2017 |
HSCB Letter to Community Pharmacies |
| Awareness of pregabalin abuse/misuse in NI - Community Pharmacists |
Oct 2016 |
|
| Awareness of pregabalin abuse/misuse in NI - General Pactice |
Oct 2016 |
|
| Storage & Denaturing of Medicines for Disposal - Community Pharmacists |
Apr 2016 |
|
| Hand written amendments to prescriptions |
Apr 2016 |
|
| Patient counselling & generic medicines (Community Pharmacy) |
Jul 2015 |
|
| Letter to community pharmacists re Further Dispensing Errors involving Beta Blockers |
Jul 2015 |
Note Appendix 1 to letter (issued to pharmacies in April 2014)
is not included (restricted issue) |
| Fraudulent Attempts to Obtain Medicines for Patients Detained in Prison |
Jul 2015 |
|
| Communication between GPs and Community Pharmacies about patient clinical concerns |
Jul 2015 |
|
| Over the Counter Medicines – Potential for abuse and misuse |
Jul 2015 |
|
| Issuing duplicate prescriptions |
May 2015 |
|
| Incidents involving newer oral anticoagulant (NOAC) dosing |
Feb 2015 |
HSCB Medicines Safety Advice Letter |
| Incidents Regarding Security of Prescription Pads |
Feb 2015 |
|
| Transdermal Fentanyl Patches |
Feb 2015 |
HSCB Medicines Safety Advice Letter to CPs and GPs |
| Requesting And Dispensing Repeat Medicaltions |
Aug 2014 |
Learning Letter |
| Safer Ambulatory Syringe Drivers |
May 2014 |
|
| Raising awareness about the newer oral anticoagulant medicines |
May 2014 |
|
| Reducing dosage errors with opioid medicines - incomplete cross tolerance |
Mar 2014 |
HSCB Letter to CPs |
| Community Pharmacist communication with GPs and management of information from secondary care |
May 2013 |
|
| Medication Requests for Care Homes |
Jan 2013 |
|
| No.12 Patient harm following pregabalin overdose |
Jan 2013 |
|
| Faxing Prescriptions |
Dec 2012 |
|
| Validation Process for registration of Pharmacists |
Nov 2012 |
|
| Misuse and diversion potential of pregabalin (Lyrica) |
Nov 2012 |
|
| No.11 Anticholinergic syndrome |
Oct 2012 |
|
| No.10 Risks with buccal midazolam |
Jun 2012 |
|
| Prescribing, generating and dispensing repeat medications |
Mar 2012 |
|
| No.9 Responsibility for prescribing & dispensing specialist medicines |
Jun 2011 |
|
| Community Pharmacy Robbery |
Apr 2011 |
|
| Supplying medicines without a prescription |
Jan 2011 |
|
| No.8 Issuing duplicate prescriptions |
Oct 2010 |
|
| No.5 Prescribing & dispensing medicines with a range of strengths & preparations |
Oct 2010 |
|
| No.6 Risks when dispensing oral liquid medicines |
Sep 2010 |
|
| No.4 Prescribing & dispensing controlled drugs |
Aug 2010 |
|
| No.3 Risks when dispensing medicines into monitored dosage systems (GPs) |
Jul 2010 |
|
| No.2 Learning from adverse events - Heparin |
Apr 2010 |
Medicines Safety Alert |
| Risks when dispensing medicines into monitored dosage systems (Community Pharmacies) |
Mar 2010 |
|
| No.1 Clinical risk when issuing repeat and acute prescriptions |
Mar 2010 |
|
